I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 23% ± 6% | |
| epithelial cell | 6 studies | 36% ± 18% | |
| abnormal cell | 4 studies | 21% ± 2% | |
| myeloid cell | 4 studies | 32% ± 13% | |
| macrophage | 4 studies | 21% ± 10% | |
| fibroblast | 4 studies | 18% ± 2% | |
| goblet cell | 4 studies | 22% ± 5% | |
| conventional dendritic cell | 3 studies | 42% ± 20% | |
| hematopoietic precursor cell | 3 studies | 41% ± 17% | |
| B cell | 3 studies | 19% ± 1% | |
| glutamatergic neuron | 3 studies | 30% ± 10% | |
| dendritic cell | 3 studies | 36% ± 13% | |
| natural killer cell | 3 studies | 16% ± 0% | |
| enteroendocrine cell | 3 studies | 20% ± 4% | |
| intestinal crypt stem cell | 3 studies | 20% ± 3% | |
| basal cell | 3 studies | 24% ± 6% | |
| transit amplifying cell | 3 studies | 29% ± 4% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 44% ± 25% | |
| erythroblast | 3 studies | 48% ± 26% |
